Screen today for a healthier tomorrow.

Prenatal Profile

PRENATAL RISK ASSESSMENT SCREENING TESTS

---

Double, Triple, and Quadruple Marker Tests are maternal serum screening tests performed during pregnancy to assess the risk of chromosomal abnormalities and neural tube defects in the foetus.

These non-invasive blood tests help in early risk assessment and informed clinical decision-making.

DOUBLE MARKER TEST

---

Purpose:

Assesses the risk of chromosomal abnormalities during the first trimester by measuring:

• PAPP-A (Pregnancy-Associated Plasma Protein-A)
• Free Beta-hCG

Timing:

• 10–14 weeks of pregnancy

Relevant Documents Required:

• Doctor’s prescription
• Patient’s date of birth
• Body weight
• Entry scan USG report

TRIPLE MARKER TEST

---

Purpose:

Provides further risk assessment for foetal abnormalities during the second trimester by analysing:

• AFP (Alpha-Fetoprotein)
• Unconjugated Estriol (uE3)
• hCG

Timing:

• 15–20 weeks of pregnancy

Relevant Documents Required:

• Doctor’s prescription
• Patient’s date of birth
• Body weight
• Entry scan USG report

QUADRUPLE MARKER TEST

---

Purpose:

A more comprehensive second-trimester screening test, expanding upon the Triple Marker Test by including:

• AFP (Alpha-Fetoprotein)
• Unconjugated Estriol (uE3)
• hCG
• Inhibin-A

Timing:

• 15–20 weeks of pregnancy

Relevant Documents Required:

• Doctor’s prescription
• Patient’s date of birth
• Body weight
• Entry scan USG report